22
Views
7
CrossRef citations to date
0
Altmetric
Review

Gene expression patterns and susceptibility to allergic responses

&
Pages 59-73 | Published online: 10 Jan 2014

References

  • Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J. Allergy Clin. Immunol. 116, 377–383 (2005).
  • Sampson HA. Clinical practice. Peanut allergy. N. Engl. J. Med. 346, 1294–1299 (2002).
  • Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Ann. Rev. Immunol. 17, 255–281 (1999).
  • Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Ann. Rev. Immunol. 22, 789–815 (2004).
  • Georas SN, Beck LA, Stellato C. What is eotaxin doing in the pleura? Insights into innate immunity from pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 26, 384–387 (2002).
  • Vercelli D. Genetic polymorphism in allergy and asthma. Curr. Opin. Immunol. 15, 609–613 (2003).
  • Hoffjan S, Nicolae D, Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir. Res. 4, 14 (2003).
  • Eder W, von Mutius E. Hygiene hypothesis and endotoxin: what is the evidence? Curr. Opin. Allergy Clin. Immunol. 4, 113–117 (2004).
  • Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N. Engl. J. Med. 343, 538–543 (2000).
  • Braun-Fahrlander C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl J. Med. 347, 869–877 (2002).
  • Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E. Atopic dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis: results from a cross-sectional study. Clin. Exp. Allergy 35, 1301–1308 (2005).
  • Celedon JC, Wright RJ, Litonjua AA et al. Day care attendance in early life, maternal history of asthma, and asthma at the age of 6 years. Am. J. Respir. Crit. Care Med. 167, 1239–1243 (2003).
  • Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Rev. Immunol. 1, 69–75 (2001).
  • Holt PG, Thomas WR. Sensitization to airborne environmental allergens: unresolved issues. Nature Immunol. 6, 957–960 (2005).
  • Robinson D, Hamid Q, Ying S et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am. Rev. Respir. Dis. 148, 401–406 (1993).
  • Robinson D, Ying S, Bentley A et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol. 92, 397–403 (1993).
  • Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl J. Med. 326, 298–304 (1992).
  • Leung DY, Martin RJ, Szefler SJ et al. Dysregulation of interleukin-4, interleukin-5, and interferon gamma gene expression in steroid-resistant asthma. J. Exp. Med. 181, 33–40 (1995).
  • Benson M, Strannegard IL, Wennergren G, Strannegard O. Low levels of interferon-γ in nasal fluid accompany raised levels of T-helper 2 cytokines in children with ongoing allergic rhinitis. Pediatr. Allergy Immunol. 11, 20–28 (2000).
  • Lee CH, Rhee CS, Oh SH, Min YG, Lee MS. Increase in expression of IL-4 and IL-5 mRNA in the nasal mucosa of patients with perennial allergic rhinitis during natural allergen exposure. Ann. Otol. Rhinol. Laryngol. 106, 215–219 (1997).
  • Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94, 870–876 (1994).
  • Martin RJ, Boguniewicz M, Henson JE et al. The effects of inhaled interferon gamma in normal human airways. Am. Rev. Respir. Dis. 148, 1677–1682 (1993).
  • Randolph DA, Stephens R, Carruthers CJ, Chaplin DD. Co-operation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J. Clin. Invest. 104, 1021–1029 (1999).
  • Ford JG, Rennick D, Donaldson DD et al. Il-13 and IFN-γ: interactions in lung inflammation. J. Immunol. 167, 1769–1777 (2001).
  • Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and interferon γ regulate allergic airway inflammation and mucus production. J. Exp. Med. 190, 1309–1318 (1999).
  • Magnan AO, Mely LG, Camilla CA et al. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-γ-producing CD8+ T cells in asthma. Am. J. Respir. Crit. Care Med. 161, 1790–1796 (2000).
  • Heaton T, Rowe J, Turner S et al. An immunoepidemiological approach to asthma: identification of in vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 365, 142–149 (2005).
  • Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J. Clin. Invest. 113, 651–657 (2004).
  • Thepen T, Langeveld-Wildschut EG, Bihari IC et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 97, 828–837 (1996).
  • Ingordo V, Dalle Nogare R, Colecchia B, D’Andria C. Is the atopy patch test with house dust mites specific for atopic dermatitis? Dermatology 209, 276–283 (2004).
  • Wollenberg A, Kraft S, Hanau D, Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J. Invest. Dermatol. 106, 446–453 (1996).
  • Novak N, Valenta R, Bohle B et al. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J. Allergy Clin. Immunol. 113, 949–957 (2004).
  • de Vries IJ, Langeveld-Wildschut EG, van Reijsen FC, Bihari IC, Bruijnzeel-Koomen CA, Thepen T. Nonspecific T-cell homing during inflammation in atopic dermatitis: expression of cutaneous lymphocyte-associated antigen and integrin αE β7 on skin-infiltrating T cells. J. Allergy Clin. Immunol. 100, 694–701 (1997).
  • Wu C, Fargeas C, Nakajima T, Delespesse G. Glucocorticoids suppress the production of interleukin-4 by human lymphocytes. Eur. J. Immunol. 21, 2645–2647 (1991).
  • Byron K, Varigo G, Wootton A. Hydrocortisone inhibition of human interleukin-4. Immunol. 77, 624–626 (1992).
  • Chikanza LC, Panayi GS. The effects of hydrocortisone on in vitro lymphocyte proliferation and interleukin-2 and -4 production in corticosteroid sensitive and resistant subjects. Eur. J. Clin. Invest. 23, 845–850 (1993).
  • Schmidt J, Fleissner S, Heimann-Weitschat I, Lindstaedt R, Szelenyi I. The effect of different corticosteroids and cyclosporin A on interleukin-4 and interleukin-5 release from murine Th2-type T cells. Eur. J. Pharmacol. 260, 247–250 (1994).
  • Krouwels F, van der Heijden J, Lutter R, van Neervan R, Jansen H, Out T. Glucocorticoids affect functions of airway and blood-derived human T cell clones. Am. J. Respir. Cell Mol. Biol. 14, 388–397 (1996).
  • Umland SP, Nahrebne DK, Razac S et al. The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-γ production by cultured primary CD4+ T cells. J. Allergy Clin. Immunol. 100, 511–519 (1997).
  • Braun CM, Huang SK, Bashian GG, Kagey-Sobotka A, Lichtenstein LM, Essayan DM. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J. Allergy Clin. Immunol. 100, 400–407 (1997).
  • Naseer T, Minshall EM, Leung DY et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit. Care Med. 155, 845–851 (1997).
  • Corrigan CJ, Hamid Q, North J et al. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-Type pattern: effect of glucocorticoid therapy. Am. J. Respir. Cell Mol. Biol. 12, 567–578 (1995).
  • Majori M, Piccoli ML, Bertacco S, Cuomo A, Cantini L, Pesci A. Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma. J. Allergy Clin. Immunol. 100, 379–382 (1997).
  • Gemou-Engesaeth V, Bush A, Kay AB, Hamid Q, Corrigan CJ. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and ‘Th2-type’ cytokine mRNA expression. Pediatrics 99, 695–703 (1997).
  • Gemou-Engesaeth V, Fagerhol MK, Toda M et al. Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy. Pediatrics 109, E24 (2002).
  • Harris NL, Watt V, Ronchese F, Le Gros G. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195, 317–326 (2002).
  • Reinhardt RL, Bullard DC, Weaver CT, Jenkins MK. Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J. Exp. Med. 197, 751–762 (2003).
  • Seki N, Miyazaki M, Suzuki W et al. IL-4-induced GATA-3 expression is a time-restricted instruction switch for Th2 cell differentiation. J. Immunol. 172, 6158–6166 (2004).
  • Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nature Rev. Immunol. 2, 933–944 (2002).
  • Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205–215 (2001).
  • Eisenbarth SC, Zhadkevich A, Ranney P, Herrick CA, Bottomly K. IL-4-dependent Th2 collateral priming to inhaled antigens independent of toll-like receptor 4 and myeloid differentiation factor 88. J. Immunol. 172, 4527–4534 (2004).
  • Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rβ2 chain or T-bet. Immunity 18, 415–428 (2003).
  • Galvao Da Silva AP, Jacysyn JF, De Almeida Abrahamsohn I. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper Type 2 response. Immunology 108, 230–237 (2003).
  • Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell Type 2 responses to inhaled antigen. J. Exp. Med. 196, 1645–1651 (2002).
  • Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742 (1997).
  • Richards DF, Fernandez M, Caulfield J, Hawrylowicz CM. Glucocorticoids drive human CD8+ T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur. J. Immunol. 30, 2344–2354 (2000).
  • Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin-10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper Type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195, 603–616 (2002).
  • Vieira PL, Christensen JR, Minaee S et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172, 5986–5993 (2004).
  • O’Garra A, Barrat FJ. In vitro generation of IL-10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by Th1- and Th2-inducing cytokines. Immunol. Lett. 85, 135–139 (2003).
  • Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388–392 (2003).
  • Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 19, 683–765 (2001).
  • Sakaguchi S. Naturally Arising CD4+ Regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann. Rev. Immunol. 22, 531–562 (2004).
  • Weiner HL. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182, 207–214 (2001).
  • Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genet. 27, 20–21 (2001).
  • Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672–37679 (2001).
  • Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330–336 (2003).
  • Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
  • Kasprowicz DJ, Smallwood PS, Tyznik AJ, Ziegler SF. Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function. J. Immunol. 171, 1216–1223 (2003).
  • Watanabe N, Wang YH, Lee HK, Ito T, Cao W, Liu YJ. Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436, 1181–1185 (2005).
  • Walker MR, Kasprowicz DJ, Gersuk VH et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112, 1437–1443 (2003).
  • Lin W, Truong N, Grossman WJ et al. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J. Allergy Clin. Immunol. 116, 1106–1115 (2005).
  • Ochs HD, Ziegler SF, Torgerson TR. Foxp3 acts as a rheostat of the immune response. Immunol. Rev. 203, 156–164 (2005).
  • Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J. Clin. Invest. 111, 1065–1072 (2003).
  • Umetsu DT, Akbari O, Dekruyff RH. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol. 112, 480–487; quiz 488 (2003).
  • Romagnani S. Immunologic influences on allergy and the Th1/Th2 balance. J. Allergy Clin. Immunol. 113, 395–400 (2004).
  • Robinson DS, Larche M, Durham SR. Tregs and allergic disease. J. Clin. Invest. 114, 1389–1397 (2004).
  • Akbari O, DeKruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol. 2, 725–731 (2001).
  • Hadeiba H, Locksley RM. Lung CD25 CD4 regulatory T cells suppress Type 2 immune responses but not bronchial hyper-reactivity. J. Immunol. 170, 5502–5510 (2003).
  • Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nature Med. 8, 625–629 (2002).
  • Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003).
  • Ling EM, Smith T, Nguyen XD et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363, 608–615 (2004).
  • Li-Weber M, Davydov I, Krafft H, Krammer P. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 153, 4122–4133 (1994).
  • Lee RL, Fields PE, Flavell RA. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14, 447–459 (2001).
  • Tykocinski LO, Hajkova P, Chang HD et al. A critical control element for interleukin-4 memory expression in T helper lymphocytes. J. Biol. Chem. 280, 28177–28185 (2005).
  • Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272, 21597–21603 (1997).
  • Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313–319 (1996).
  • Peng SL, Gerth AJ, Ranger AM, Glimcher LH. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14, 13–20 (2001).
  • Ho AM, Jain J, Rao A, Hogan PG. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J. Biol. Chem. 269, 28181–28186 (1994).
  • Li B, Tournier C, Davis RJ, Flavell RA. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. Embo. J. 18, 420–432 (1999).
  • Fowell DJ, Shinkai K, Liao XC et al. Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells. Immunity 11, 399–409 (1999).
  • Marsland BJ, Soos TJ, Spath G, Littman DR, Kopf M. Protein kinase C τ is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200, 181–189 (2004).
  • Ray A, Cohn L. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin. Invest. 104, 985–993 (1999).
  • Ting CN, Olson MC, Barton KP, Leiden JM. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384, 474–478 (1996).
  • Zhu J, Min B, Hu-Li J et al. Conditional deletion of Gata3 shows its essential function in Th1-Th2 responses. Nature Immunol. 5, 1157–1165 (2004).
  • Yamashita M, Ukai-Tadenuma M, Kimura M et al. Identification of a conserved GATA3 response element upstream proximal of the IL-13 gene locus. J. Biol. Chem. 29, 29 (2002).
  • Yamashita M, Ukai-Tadenuma M, Miyamoto T et al. Essential role of GATA3 for the maintenance of Th2 cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J. Biol. Chem. 279(26), 26983–26990 (2004).
  • Zhang DH, Yang L, Cohn L et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11, 473–482 (1999).
  • Nakamura Y, Ghaffar O, Olivenstein R et al. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J. Allergy Clin. Immunol. 103, 215–222 (1999).
  • Nakamura Y, Christodoulopoulos P, Cameron L et al. Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge. J. Allergy Clin. Immunol. 105, 1146–1152 (2000).
  • Arakawa S, Hatano Y, Katagiri K. Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin. Exp. Immunol. 135, 505–510 (2004).
  • Caramori G, Lim S, Ito K et al. Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies. Eur. Respir. J. 18, 466–473 (2001).
  • Pykalainen M, Kinos R, Valkonen S et al. Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J. Allergy Clin. Immunol. 115, 80–87 (2005).
  • Georas S, Cumberland J, Burke T, Chen R, Schindler U, Casolaro V. Stat6 inhibits interleukin-4 promoter activity in T cells. Blood 92, 4529–4538 (1998).
  • Dorado B, Jerez MJ, Flores N, Martin-Saavedra FM, Duran C, Ballester S. Autocrine IL-4 gene regulation at late phases of TCR activation in differentiated Th2 cells. J. Immunol. 169, 3030–3037 (2002).
  • Lee DU, Rao A. Molecular analysis of a locus control region in the T helper 2 cytokine gene cluster: a target for STAT6 but not GATA3. Proc. Natl Acad. Sci. USA 101, 16010–16015 (2004).
  • Zhu J, Guo L, Min B et al. Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. Immunity 16, 733–744 (2002).
  • Kurata H, Lee HJ, O’Garra A, Arai N. Ectopic expression of activated Stat6 induces the expression of Th2- specific cytokines and transcription factors in developing Th1 cells. Immunity 11, 677–688 (1999).
  • Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187, 939–948 (1998).
  • Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J. Immunol. 168, 2020–2027 (2002).
  • Christodoulopoulos P, Cameron L, Nakamura Y et al. Th2 cytokine-associated transcription factors in atopic and nonatopic asthma: evidence for differential signal transducer and activator of transcription 6 expression. J. Allergy Clin. Immunol. 107, 586–591 (2001).
  • Ghaffar O, Christodoulopoulos P, Lamkhioued B et al. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids. Clin. Exp. Allergy 30, 86–93 (2000).
  • Heller NM, Matsukura S, Georas SN, Boothby MR, Stellato C, Schleimer RP. Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells. Clin. Exp. Allergy 34, 1690–1700 (2004).
  • Tamura K, Arakawa H, Suzuki M et al. Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases. Clin. Exp. Allergy 31, 1509–1514 (2001).
  • Duetsch G, Illig T, Loesgen S et al. STAT6 as an asthma candidate gene: polymorphism-screening, association and haplotype analysis in a Caucasian sib-pair study. Hum. Mol. Genet. 11, 613–621 (2002).
  • Macian F. NFAT proteins: key regulators of T-cell development and function. Nature Rev. Immunol. 5, 472–484 (2005).
  • Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205–2232 (2003).
  • Crabtree GR. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NFAT. Cell 96, 611–614 (1999).
  • Seminario CS, Burke T, Bochner B, Georas S. Detection of an NFAT-like protein in human eosinophils. Am. J. Respir. Crit. Care Med. 155, A58 (1997).
  • Reddy SP, Mossman BT. Role and regulation of activator protein-1 in toxicant-induced responses of the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L1161–L1178 (2002).
  • Ogawa K, Kaminuma O, Okudaira H et al. Transcriptional regulation of the IL-5 gene in peripheral T cells of asthmatic patients. Clin. Exp. Immunol. 130, 475–483 (2002).
  • Ho IC, Hodge MR, Rooney JW, Glimcher LH. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973–983 (1996).
  • Ho IC, Lo D, Glimcher LH. c-maf promotes T helper cell Type 2 (Th2) and attenuates Th1 differentiation by both interleukin-4-dependent and -independent mechanisms. J. Exp. Med. 188, 1859–1866 (1998).
  • Hodge MR, Chun HJ, Rengarajan J, Alt A, Lieberson R, Glimcher LH. NF-AT-Driven interleukin-4 transcription potentiated by NIP45. Science 274, 1903–1905 (1996).
  • Kim JI, Ho IC, Grusby MJ, Glimcher LH. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10, 745–751 (1999).
  • Cousins DJ, Lee TH, Staynov DZ. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for co-ordinated expression of Th2 cytokines. J. Immunol. 169, 2498–2506 (2002).
  • Li-Weber M, Salgame P, Hu C et al. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter. J. Immunol. 161, 1380–1389 (1998).
  • Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nature Immunol. 4, 616–623 (2003).
  • Agarwal S, Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9, 765–775 (1998).
  • Solymar DC, Agarwal S, Bassing CH, Alt FW, Rao A. A 3’ enhancer in the IL-4 gene regulates cytokine production by Th2 cells and mast cells. Immunity 17, 41–50 (2002).
  • Wang Y, Fischle W, Cheung W, Jacobs S, Khorasanizadeh S, Allis CD. Beyond the double helix: writing and reading the histone code. Novartis Found Symp. 259, 3–17; discussion 17–21, 163–169 (2004).
  • Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
  • Valapour M, Guo J, Schroeder JT et al. Histone deacetylation inhibits IL4 gene expression in T cells. J. Allergy Clin. Immunol. 109, 238–245 (2002).
  • Fields PE, Kim ST, Flavell RA. Cutting edge: changes in histone acetylation at the IL-4 and IFN-γ loci accompany Th1/Th2 differentiation. J. Immunol. 169, 647–650 (2002).
  • Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. Active recruitment of DNA methyltransferases regulates interleukin-4 in thymocytes and T cells. Nature Immunol. 4, 1183–1190 (2003).
  • Santangelo S, Cousins DJ, Winkelmann NE, Staynov DZ. DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4+ T cell differentiation. J. Immunol. 169, 1893–1903 (2002).
  • Lee DU, Agarwal S, Rao A. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 16, 649–660 (2002).
  • Ansel KM, Greenwald RJ, Agarwal S et al. Deletion of a conserved IL-4 silencer impairs T helper Type 1-mediated immunity. Nature Immunol. 5, 1251–1259 (2004).
  • Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).
  • Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in Th1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338–342 (2002).
  • Afkarian M, Sedy JR, Yang J et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nature Immunol. 3, 549–557 (2002).
  • Mullen AC, High FA, Hutchins AS et al. Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 292, 1907–1910 (2001).
  • Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307, 430–433 (2005).
  • Finotto S, De Sanctis GT, Lehr HA et al. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 193, 1247–1260 (2001).
  • Breuer K, Wittmann M, Kempe K et al. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper Type 1 response in atopic dermatitis. Clin. Exp. Allergy 35, 1088–1095 (2005).
  • Tantisira KG, Hwang ES, Raby BA et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc. Natl Acad. Sci. USA 101, 18099–18104 (2004).
  • Raby BA, Hwang ES, Van Steen K et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med.173(1), 64–70 (2006).
  • Lambrecht BN, Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nature Rev. Immunol. 3, 994–1003 (2003).
  • Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am. J. Respir. Crit. Care Med. 172, 530–551 (2005).
  • Holt PG, Haining S, Nelson DJ, Sedgwick JD. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153, 256–261 (1994).
  • McWilliam AS, Nelson D, Thomas JA, Holt PG. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J. Exp. Med. 179, 1331–1336 (1994).
  • Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady-state conditions in vivo. J. Exp. Med. 194, 769–779 (2001).
  • Steinman RM, Nussenzweig MC. Inaugural article: avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA 99, 351–358 (2002).
  • Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann. Rev. Immunol. 21, 335–376 (2003).
  • Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257–263 (2004).
  • Caux C, Massacrier C, Vanbervliet B et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180, 1263–1272 (1994).
  • Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184, 747–752 (1996).
  • MacDonald AS, Straw AD, Dalton NM, Pearce EJ. Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J. Immunol. 168, 537–540 (2002).
  • Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation [see comments]. Science 283, 1183–1186 (1999).
  • Turley SJ, Inaba K, Garrett WS et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288, 522–527 (2000).
  • Caux C, Vanbervliet B, Massacrier C et al. B70/B7–2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180, 1841–1847 (1994).
  • Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells. Nature Immunol. 1, 311–316 (2000).
  • Ebner S, Ratzinger G, Krosbacher B et al. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4. J. Immunol. 166, 633–641 (2001).
  • Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
  • Lanzavecchia A, Sallusto F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nature Immunol. 2, 487–492 (2001).
  • Lanzavecchia A, Sallusto F. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13, 291–298 (2001).
  • Huang Q, Liu D, Majewski P et al. The plasticity of dendritic cell responses to pathogens and their components. Science 294, 870–875 (2001).
  • Ronnblom L, Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 194, F59–F63 (2001).
  • Gilliet M, Boonstra A, Paturel C et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953–958 (2002).
  • Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum. 48, 2524–2532 (2003).
  • Diebold SS, Montoya M, Unger H et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424, 324–328 (2003).
  • Asselin-Paturel C, Boonstra A, Dalod M et al. Mouse Type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nature Immunol. 2, 1144–1150 (2001).
  • Ronnblom L, Eloranta ML, Alm GV. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. AutoImmunity 36, 463–472 (2003).
  • Boonstra A, Asselin-Paturel C, Gilliet M et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper Type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 197, 101–109 (2003).
  • Charbonnier AS, Hammad H, Gosset P et al. Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response. J. Leukoc. Biol. 73, 91–99 (2003).
  • Kuipers H, Hijdra D, De Vries VC et al. Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J. Immunol. 171, 3645–3654 (2003).
  • Redecke V, Hacker H, Datta SK et al. Cutting edge: activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J. Immunol. 172, 2739–2743 (2004).
  • Traidl-Hoffmann C, Mariani V, Hochrein H et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper Type 2 cell polarization. J. Exp. Med. 201, 627–636 (2005).
  • Kalinski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote Type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159, 28–35 (1997).
  • Boldogh I, Bacsi A, Choudhury BK et al. ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J. Clin. Invest. 115, 2169–2179 (2005).
  • Ranganath S, Murphy KM. Structure and specificity of GATA proteins in Th2 development. Mol. Cell Biol. 21, 2716–2725 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.